T/CI 310-2024
Active
Group standards
T/CI 310-2024 Evaluating the blocking agent performance in raw materials for in vitro diagnostic products
T/CI 310-2024 Evaluating the blocking agent performance in raw materials for in vitro diagnostic products
Price:
$ 20.00
Basic Information
Standard Code:
T/CI 310-2024
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
Medical devices
ICS Name:
Laboratory medicine
Publish Date:
2024-03-25
Implement Date:
2024-03-25
Scope
Main technical content: This document specifies the general requirements for the evaluation of the performance of blockers in the raw materials of in vitro diagnostic products, evaluation methods, basic requirements for blockers, detection procedures, precautions for testing, performance reports, and changes and reassessments in performance evaluation studies. This document is applicable to the performance evaluation of blockers in in vitro diagnostic products, based on qualitative or quantitative measurements and the evaluation of the impact of eliminating interference on in vitro diagnostic detection systems through threshold judgment results.
Development Information
Related Standards
YY/T 0456.1-2003
Replaced
YY/T 0456.2-2003
Replaced
YY/T 0456.2-2003 Regents for hematology analyzer use—Part 2:Hemolysin
YY/T 0456.3-2003
Replaced
YY/T 0456.3-2003 Regents for hematology analyzer use—Part 3:Diluent
YY/T 0475-2004
Replaced
YY/T 0475-2004 General technical requirements for urine analyzer
YY/T 0478-2004
Replaced
YY/T 0478-2004 General technical requirements for chemical reagent strips for urinalysis
YY/T 0032-2004
Active